Finance

Beta
Lists
300254:SHE
Shanxi C&Y Pharmaceutical Group Co Ltd
CNÂ¥9.62
-4.75%
(-0.48) 1D
Jun 10, 3:04:46 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300254...
Open
CNÂ¥10.09
High
CNÂ¥10.09
Low
CNÂ¥9.37
Mkt. cap
2.33B
Avg. vol.
16.56M
Volume
15.33M
P/E ratio
135.36
52-wk high
CNÂ¥15.20
52-wk low
CNÂ¥9.04
EPS
CNÂ¥0.07
Shares outstanding
256.06M
No. of employees
1K
Open
CNÂ¥10.09
High
CNÂ¥10.09
Low
CNÂ¥9.37
Mkt. cap
2.33B
Avg. vol.
16.56M
Volume
15.33M
P/E ratio
135.36
52-wk high
CNÂ¥15.20
52-wk low
CNÂ¥9.04
EPS
CNÂ¥0.07
Shares outstanding
256.06M
No. of employees
1K
News stories
From sources across the web
About Shanxi C&Y Pharmaceutical Group Co Ltd
CEO-
Employees1.16K
FoundedMar 23, 2005
Headquarters-
SectorPharmaceutical industry
Websitecy-pharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
191.26M
238.48M
259.31M
173.80M
Cost of goods sold
59.91M
82.04M
87.88M
57.40M
Cost of revenue
59.91M
82.04M
87.88M
57.40M
Research and development expenses
14.83M
9.44M
13.63M
12.74M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
96.18M
98.94M
123.96M
92.97M
Operating expense
112.32M
113.82M
138.78M
106.27M
Total operating expenses
172.23M
195.87M
226.66M
163.67M
Operating income
19.03M
42.61M
32.65M
10.13M
Other non operating income
4.07M
-2.49M
9.70M
7.65M
EBT including unusual items
13.31M
41.81M
13.42M
13.39M
EBT excluding unusual items
17.27M
35.80M
40.89M
13.40M
Income tax expense
16.18M
9.67M
5.46M
5.42M
Effective tax rate
121.50%
23.13%
40.66%
40.50%
Other operating expenses
1.90M
2.38M
-1.34M
902.35K
Net income
-10.01M
21.95M
2.52M
3.34M
Net profit margin
-5.23%
9.20%
0.97%
1.92%
Earnings per share
-
-
-
-
Interest and investment income
147.05K
1.39M
2.54M
949.72K
Interest expense
-5.98M
-5.70M
-4.00M
-5.34M
Net interest expenses
-5.83M
-4.32M
-1.46M
-4.39M
Depreciation and amortization charges
-
-
-
-
EBITDA
32.20M
55.33M
45.40M
22.88M
Gain or loss from assets sale
-7.90M
7.90M
-8.94M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer